跳至主要内容
临床试验/NCT05595226
NCT05595226招募中不适用

Effect of RT3D-TEE-guided Mitral Valve Repair on Outcomes in Patients With Degenerative Mitral Valve Disease

Sheng Liu1 个研究点 分布在 1 个国家目标入组 338 人开始时间: 2021年12月31日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
338
试验地点
1
主要终点
Composite events of mitral valve repair failure and 1-year reoccurrence of mitral regurgitation

研究概览

简要总结

The aim of this randomized controlled trial to investigate the effects of Real-time 3D transesophageal echocardiography (RT3D-TEE)-guided mitral valve repair on surgical failure and 1-year reoccurrence of mitral valve regurgitation in patients with degenerative mitral value disease.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosed with chronic primary degenerative mitral regurgitation by the preoperative echocardiogram.
  • Informed consent was obtained

排除标准

  • Re-operation of mitral regurgitation
  • Concurrent surgical plan for congenital heart disease, coronary artery bypass grafting, aortic valve surgery, radiofrequency ablation of atrial fibrillation and other cardiac surgeries.
  • Mitral valve replacement
  • Unable to undergo TEE

结局指标

主要结局

Composite events of mitral valve repair failure and 1-year reoccurrence of mitral regurgitation

时间窗: 1 year

mitral valve repair failure, 1-year reoccurrence of mitral regurgitation

次要结局

  • The incidence of secondary transfer, perioperative complications(1 year)
  • Intraoperative conditions including extracorporeal circulation time, aortic occlusion time(1 year)
  • The recurrence rate of residual mitral valve regurgitation(1 year)
  • Individual occurrence of composite endpoints of mitral valve repair failure and 1-year reoccurrence of mitral regurgitation(1 year)

研究者

发起方
Sheng Liu
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Sheng Liu

Principal Investigator

Chinese Academy of Medical Sciences, Fuwai Hospital

研究点 (1)

Loading locations...

相似试验